Malonyl-CoA is a potent inhibitor of fatty acid oxidation (McGarry et al., 1977) , especially in liver preparations from fed animals (Cook et al., 1978) , and the site of inhibition is the carnitine palmitoyltransferase step (McGarry et al., 1977 (McGarry et al., , 1978 . In mitochondria from starved animals, however, fatty acid oxidation is resistant to inhibition by malonyl-CoA (Cook et al., 1980; Ontko & Johns, 1980) , and that resistance to inhibition is due to a difference in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA (Bremer, 1981; Saggerson & Carpenter, 1981) . These studies suggest that carnitine palmitoyltransferase may be under some type of hormonal control, probably involving insulin and/or glucagon. More recently, some evidence has been presented that indicates such a mechanism exists (Harano et al., 1982) , but studies by Saggerson & Carpenter (1981) Liver mitochondria were isolated by the method of Johnson & Lardy (1967) , and the final mitochondrial pellet was resuspended to a protein concentration of 10mg/ml in 0.25M-sucrose, adjusted to pH7.2 by adding a few drops of 2M-Tris base. Protein was determined by a biuret procedure (Gornall et al., 1949) . Respiratory control ratios (Estabrook, 1967) were 5 or greater with 10mM-glutamate and 0.5mM-malate as substrates.
Carnithine palmitoyltransferase activity was measured by a modification (Stephens et al., 1983) of the method of Bremer (1981) . Each assay contained, in a total volume of 1 ml: 82mM-sucrose, 
Results and discussion
As intact mitochondria were used in these studies, only the carnitine palmitoyltransferase on the outer surface of the mitochondrial inner membrane was measured in our assay. The shape of the malonyl-CoA inhibition curve ( Fig. 1) indicates that inhibition approached 100% in mitochondria from fed rats. As reported previously (Bremer, 1981; Saggerson & Carpenter, 1981) , we also observed that the I50 (inhibitor concentration giving 50% inhibition) for malonyl-CoA inhibition of carnitine palmitoyltransferase was much greater in mitochondria from starved rats. Although inhibition of the enzyme in mitochondria from starved rats was only 70% at 50fiM, the highest concentration tested, the maximum inhibition approached 100%, and additional experiments with higher concentrations (100-300pM) of malonyl-CoA have shown much greater inhibition. These results suggest that the mitochondria used in these experiments were intact and did not allow any of the inner carnitine palmitoyltransferase to be assayed. McGarry et al. (1978) have indicated that the inner enzyme is not inhibited by malonylCoA, so that inhibition of carnitine palmitoyltransferase by malonyl-CoA in broken mitochondria reaches a maximum of 50%.
At the time diabetic animals were used for these experiments, their stomachs were distended with food; the stomachs of the diabetic animals were much more distended than those of the normal fed animals, suggesting the typical hyperphagia of insulin-dependent diabetes. The diabetic animals were therefore well fed, but there were undoubtedly changes in metabolism because of their altered hormonal state.
In contrast with experiments reported by Saggerson & Carpenter (1981), our results indicated that mitochondria from streptozotocin-treated rats were almost identical with those from starved rats, i.e. carnitine palmitoyltransferase from both of these groups exhibited diminished sensitivity to malonyl-CoA inhibition. Our results would support the hypothesis that changes in sensitivity of carnitine palmitoyltransferase to malonyl-CoA [Malonyl-CoAI (uM) Fig. 1 Opie, 1968; Forster & Rudas, 1969; Junod et al., 1969; Schein et al., 1971) . Although Saggerson & Carpenter (1981) reported that their animals were hyperglycaemic, no data were presented on ketone-body concentrations. In previous experiments (Gillim et al., 1983) we found that the 150mg/kg dose of streptozotocin increased liver ketone bodies to 15 times that of the control animals, results similar to those reported by other laboratories (Schein et al., 1971; Topping & Targ, 1975) . Blood ketone bodies of the diabetic animals used in the experiments reported here were 5.31 +0.62pmol/ml; blood glucose was 25.8 + 0.2!mol/ml (mean + S.E.M., n = 3). Another important difference between our experiments and those of Saggerson & Carpenter (1981) was the length of time between injection of streptozotocin and use of the diabetic animals. Wieland (1968) has cautioned against the use of chronically diabetic rats because of the depletion of fat stores, and he has pointed out that chronically diabetic rats do not represent an adequate model for the uncontrolled human diabetic. Topping & Targ (1975) , using rats that had been given a 100mg/kg dose of streptozotocin, found that both plasma non-esterified fatty acids and ketone bodies were maximally increased at 48 h after injection and concluded that 48 h was the most advantageous time for studying experimental diabetes induced by streptozotocin.
The mechanism by which changes in the sensitivity of carnitine palmitoyltransferase occur is not known, but the finding that diabetic rats, like starved rats, have a diminished sensitivity to inhibition by malonyl-CoA strongly suggests that the mechanism operates under hormonal control.
